Personal tools

MCL coexpression mm9:693: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0002107!1.23e-10!22;UBERON:0007499!1.23e-10!22;UBERON:0006925!1.23e-10!22;UBERON:0009497!1.23e-10!22;UBERON:0000015!1.23e-10!22;UBERON:0002423!1.23e-10!22;UBERON:0006235!1.23e-10!22;UBERON:0008835!1.23e-10!22;UBERON:0003894!1.23e-10!22;UBERON:0004161!1.23e-10!22;UBERON:0008836!1.23e-10!22;UBERON:0009854!1.34e-09!23;UBERON:0009856!1.34e-09!23;UBERON:0001264!1.58e-08!12;UBERON:0002365!2.99e-08!25;UBERON:0002330!2.99e-08!25;UBERON:0005256!3.44e-07!45
|ontology_enrichment_uberon=UBERON:0002107!1.23e-10!22;UBERON:0007499!1.23e-10!22;UBERON:0006925!1.23e-10!22;UBERON:0009497!1.23e-10!22;UBERON:0000015!1.23e-10!22;UBERON:0002423!1.23e-10!22;UBERON:0006235!1.23e-10!22;UBERON:0008835!1.23e-10!22;UBERON:0003894!1.23e-10!22;UBERON:0004161!1.23e-10!22;UBERON:0008836!1.23e-10!22;UBERON:0009854!1.34e-09!23;UBERON:0009856!1.34e-09!23;UBERON:0001264!1.58e-08!12;UBERON:0002365!2.99e-08!25;UBERON:0002330!2.99e-08!25;UBERON:0005256!3.44e-07!45
|tfbs_overrepresentation_for_novel_motifs=0.321524,0.178895,0.297937,0.360062,0.200163,0.373426,0.458558,0.124431,1.91731,1.12691,1.071,0.447169,0.124608,0.470194,0.214197,0,0.656089,0.19356,1.76573,0.786777,0.26524,0.954669,0.469335,1.71972,0.304728,0.496413,0.709649,0.392919,0.67135,0.572447,0.989437,0.754912,2.38223,1.07782,1.1554,0.102262,0.184038,0.443753,0.166348,1.39973,0.196807,0.38461,0.890234,0.215898,1.68044,1.6507,0.578773,0.407653,0.479635,0.677281,0.639101,0.522137,0.935589,0.894161,0.911367,1.20022,0.249055,1.11002,0.101408,1.19606,0.735292,0.531188,0.854737,0.628155,0.487593,0.667546,1.04613,1.3932,0.730718,1.24673,2.15451,0.128829,0.356247,0.944464,1.09617,0.0893951,0.0942164,0.567793,0.718494,0.268962,0.406536,0.673009,0.529804,0.380754,0.830765,4.62561,0.182066,0.271714,1.42647,1.55487,1.11522,0.835661,0.767462,0.205117,1.51576,0.149272,0.388243,0.770215,3.54303,0.50528,0.184103,0.754637,0.87698,0.639679,0.638654,0.3842,0.696857,0.403887,0.273261,0.266818,0.845852,0.878738,0.26996,1.89958,1.12221,0.195318,0.993542,0.953611,0.657356,0.181004,0.949798,0.607824,0.498153,0.566919,1.17594,0.722111,0.466292,0.760818,1.04463,0.207624,0.86025,0.353344,1.01535,0.48999,1.14365,0.33206,0.329172,0.385921,1.09487,1.92247,1.5231,1.0508,0.509663,0.765172,0.632358,0.385031,0.581788,1.88287,3.31507,0.201635,1.46048,0.305197,0.895708,0.153911,0.489108,0.976367,0.523103,0.637798,0.319291,0.876739,2.49793,0.829923,0.722546,0.313083,0.629147,0.482049,1.63125,0.445669,0.19482
}}
}}

Revision as of 18:45, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr10:79723648..79723690,-p1@Gamt
Mm9::chr10:79723704..79723720,-p2@Gamt
Mm9::chr10:79723749..79723758,-p4@Gamt
Mm9::chr10:79723760..79723771,-p3@Gamt
Mm9::chr10:87324040..87324051,+p14@Igf1
Mm9::chr15:98558459..98558464,-p@chr15:98558459..98558464
-
Mm9::chr4:144483114..144483127,+p9@Dhrs3
Mm9::chr7:72947916..72947934,+p@chr7:72947916..72947934
+
Mm9::chr8:74067075..74067113,+p@chr8:74067075..74067113
+
Mm9::chr8:96910386..96910409,+p1@Herpud1


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0035264multicellular organism growth0.0176644566200871
GO:0030731guanidinoacetate N-methyltransferase activity0.0176644566200871
GO:0005159insulin-like growth factor receptor binding0.0176644566200871
GO:0006601creatine biosynthetic process0.0176644566200871
GO:0018445prothoracicotrophic hormone activity0.0176644566200871
GO:0033143regulation of steroid hormone receptor signaling pathway0.0176644566200871
GO:0006600creatine metabolic process0.0176644566200871
GO:0042396phosphagen biosynthetic process0.0176644566200871
GO:0050650chondroitin sulfate proteoglycan biosynthetic process0.021406770417925
GO:0050654chondroitin sulfate proteoglycan metabolic process0.021406770417925
GO:0006599phosphagen metabolic process0.021406770417925
GO:0030104water homeostasis0.0247732094639659
GO:0018987osmoregulation0.0247732094639659
GO:0021940positive regulation of granule cell precursor proliferation0.0247732094639659
GO:0021936regulation of granule cell precursor proliferation0.0247732094639659
GO:0048009insulin-like growth factor receptor signaling pathway0.0247732094639659
GO:0021534cell proliferation in hindbrain0.0247732094639659
GO:0021924cell proliferation in the external granule layer0.0247732094639659
GO:0021930granule cell precursor proliferation0.0247732094639659
GO:0030518steroid hormone receptor signaling pathway0.0305848572924333
GO:0030166proteoglycan biosynthetic process0.0358385983338119
GO:0030522intracellular receptor-mediated signaling pathway0.037226303460844
GO:0005184neuropeptide hormone activity0.037226303460844
GO:0006029proteoglycan metabolic process0.037226303460844
GO:0030879mammary gland development0.0413663738297994
GO:0009887organ morphogenesis0.0465295563906256
GO:0042398amino acid derivative biosynthetic process0.0485262686279161
GO:0044272sulfur compound biosynthetic process0.0485262686279161
GO:0051789response to protein stimulus0.0485262686279161
GO:0006986response to unfolded protein0.0485262686279161



Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
liver1.23e-1022
epithelial sac1.23e-1022
digestive gland1.23e-1022
epithelium of foregut-midgut junction1.23e-1022
anatomical boundary1.23e-1022
hepatobiliary system1.23e-1022
foregut-midgut junction1.23e-1022
hepatic diverticulum1.23e-1022
liver primordium1.23e-1022
septum transversum1.23e-1022
liver bud1.23e-1022
digestive tract diverticulum1.34e-0923
sac1.34e-0923
pancreas1.58e-0812
exocrine gland2.99e-0825
exocrine system2.99e-0825
trunk mesenchyme3.44e-0745


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}